Fluorescence Angiography in the Assessment of DIEP Flap Perfusion

Indocyanine Green Fluorescence Angiography in the Assessment of Deep Inferior Epigastric Perforator (DIEP) Flap Perfusion

It is a single-center, prospective, randomized and controlled study focused in microsurgical autologous breast reconstruction. It involves applying indocyanine green (ICG) angiography for the study of the vascularization of DIEP flaps. The aim of the study is to determine whether there are differences in complications and aesthetic results when ICG is used to discard the poorly vascularized areas of the flap. The study includes adult women undergoing unilateral DIEP flap breast reconstruction. The calculated sample size is 60 patients. There are two groups. In group 1, the investigators use the usual clinical criteria to discard the poorly vascularized areas of the flap. In group 2, the investigators use the ICG to shape the flap.

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Madrid, Spain, 28046
        • La Paz University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Mastectomized adult female patient
  • Abdominal flap unilateral breast reconstruction indication
  • Alloplastic breast reconstruction sequelae
  • Enough amount of abdominal dermofat tissue to shape a breast with a primary closure of the donor site

Exclusion Criteria:

  • DIEP flap bilateral breast reconstruction indication
  • Previous abdominoplasty surgery
  • Untreated psychiatric disease
  • Untreated infection
  • Indocyanine green or iodine hypersensitivity
  • Hyperthyroidism, thyroid adenoma or thyroid autonomy
  • Any concomitant disease or condition that, in the opinion of the investigator, can make the patient unsuitable to receive a microsurgical technique or to join the research.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: Clinical assessment of flap perfusion
Tailoring the flap according to clinical assessment of flap perfusion
After microvascular anastomosis is performed, the investigators clinically assess flap vascularization and the well vascularized tissue is marked by means of a dermographic pencil. Then the investigators administer 0,2mg/kg of ICG intravenously. The vascularization of the flap is also checked by means of the Photo Dynamic Eye (Pulsion Medical System) but finally the decision of discarding the poorly vascularized areas of the flap is made by clinical assessment.
EXPERIMENTAL: Angiography assessment of flap perfusion
Tailoring the flap according to ICG Angiography assessment of flap perfusion
After microvascular anastomosis is performed, the investigators administer 0,2mg/kg of ICG intravenously. Then the investigators check the vascularization of the flap by means of the Photo Dynamic Eye (Pulsion Medical System) and the poorly vascularized areas of the flap are discarded guided by ICG perfusion test.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of participants with fat necrosis as assessed by physical examination
Time Frame: Six months postoperatively
Six months postoperatively
Number of participants with fat necrosis as assessed by ultrasonography
Time Frame: Six months postoperatively
Six months postoperatively

Secondary Outcome Measures

Outcome Measure
Time Frame
Number of participants with flap failure as assessed by physical examination
Time Frame: From intraoperative moment to one week postoperatively
From intraoperative moment to one week postoperatively
Number of participants with wound infection as assessed by physical examination
Time Frame: From one day postoperatively to two weeks postoperatively
From one day postoperatively to two weeks postoperatively
Number of participants with wound healing delay as assessed by physical examination
Time Frame: From two weeks postoperatively to two months postoperatively
From two weeks postoperatively to two months postoperatively
Number of participants with reoperation
Time Frame: From immediate postoperative moment to one year postoperatively
From immediate postoperative moment to one year postoperatively
Flap perfusion index as assessed by IC-CALC software (Pulsion Medical System)
Time Frame: Intraoperatively
Intraoperatively
Flap weight (grams)
Time Frame: Intraoperatively
Intraoperatively
Flap length (centimeters)
Time Frame: Intraoperatively
Intraoperatively
Breast-Q questionnaire (preoperative reconstruction module) to measure patient preoperative status
Time Frame: A preoperative test in the last week before surgery
A preoperative test in the last week before surgery
Breast-Q questionnaire (postoperative reconstruction module) to measure patient postoperative status
Time Frame: A postoperative test one year after surgery
A postoperative test one year after surgery
ICG security (Number of participants with tachycardia, exanthema and anaphylactic shock as assessed by physical examination and intraoperative monitoring)
Time Frame: Intraoperatively
Intraoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Luis Landín Jarillo, MD, PhD, La Paz University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2015

Primary Completion (ACTUAL)

April 1, 2017

Study Completion (ACTUAL)

April 1, 2017

Study Registration Dates

First Submitted

April 5, 2016

First Submitted That Met QC Criteria

April 29, 2016

First Posted (ESTIMATE)

May 3, 2016

Study Record Updates

Last Update Posted (ACTUAL)

April 24, 2017

Last Update Submitted That Met QC Criteria

April 21, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • idipaz

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on Tailoring the flap according to clinical assessment

3
Subscribe